Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia

Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia

Background. One approach to improving overall and relapsefree survival for patients with acute leukemia is allogeneic hematopoietic stem cell transplantation (allo-HSCT). The probability of relapse after allo-HSCT in acute leukemia patients may be influenced by many factors, including the presence o...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Galtseva, E. N. Parovichnikova, Yu. O. Davydova, N. M. Kapranov, K. A. Nikiforova, Yu. A. Chabaeva, L. A. Kuzmina, Z. V. Konova, I. S. Kastrikina, O. A. Aleshina, I. A. Lukianova, V. V. Troitskaya, T. V. Gaponova, S. M. Kulikov
Format: Article
Language:Russian
Published: ABV-press 2024-12-01
Series:Онкогематология
Subjects:
hematopoietic stem cell transplantation
acute leukemia
flow cytometry
minimal residual disease
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/975
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/975

Similar Items